SCHEMBL24287411

SCHEMBL24287411

Cc1ccccc1Oc1nc(N)nc2c1CCc1ccccc1-2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 6/20 0.51
▸ HRH2 P25021 1/20 0.51
▸ HRH1 P35367 1/20 0.51
▸ HRH3 Q9Y5N1 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ POLB P06746 1/20 0.46
▸ HPGD P15428 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ ATM Q13315 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ BCHE P06276 2/20 0.45
▸ ACHE P22303 1/20 0.45
▸ ADORA2A P29274 2/20 0.44
▸ ADORA1 P30542 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287240 0.87 MAPT (0.42) HRH4HRH2HRH1HRH3ALDH1A1
SCHEMBL26813159 0.82 LMNA (0.39) HRH4HRH2HRH1HRH3ALDH1A1
SCHEMBL4588982 0.72 HRH4 (0.57) HRH4HRH2HRH1HRH3ALDH1A1
SCHEMBL4877642 0.72 BCHE (0.57) HRH4HRH2HRH1HRH3ALDH1A1
SCHEMBL24309782 0.71 ADORA2A (0.47) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL26813383 0.71 HTR1A (0.40) HRH4HRH2HRH1HRH3KDM4E
SCHEMBL2166315 0.70 ALDH1A1 (0.49) HRH4HRH2HRH1HRH3ALDH1A1
SCHEMBL4878194 0.70 ALDH1A1 (0.47) HRH4HRH2HRH1HRH3ALDH1A1
SCHEMBL602772 0.70 HRH4 (0.47) HRH4HRH2HRH1HRH3ALDH1A1
SCHEMBL4876866 0.69 ALDH1A1 (0.46) HRH4HRH2HRH1HRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback